Download Ranitidine - King Edward Memorial Hospital

WOMEN AND NEWBORN HEALTH SERVICE
King Edward Memorial Hospital
CLINICAL GUIDELINES
PHARMACY AND MEDICATION
MEDICATION A-Z
The information provided is for the use in Obstetrics and Gynaecology only
Drug
RANITIDINE
Presentation
Tablet: 150mg
Tablet: 300mg
Injection: 50mg/5mL
WNHS Restrictions
Oral: 300mg once daily OR 150mg once or twice daily
IV: 50mg every 6 to 8 hours
Dose
Oral: Take with or without food
IV injection: Dilute 50mg to 20mL with sodium chloride 0.9% and
inject over 5 minutes
Administration
IV infusion: Dilute 50mg to 100mL with sodium chloride 0.9% and
infuse over 15 to 20 minutes or over 120 minutes. May also be given
as a continuous infusion. Dilute 150mg in 250mL of sodium chloride
0.9% or compatible fluid and infuse at a rate of 6.25mg/hour over 24
hours
Clinical guideline
links
Minor Symptoms or Disorders in Pregnancy
External Cephalic Version
Prevention of gastric aspiration in pregnant women
Other guidelines or
policy links
Women and Newborn Health Service Policy: Administration of
Parenteral Drugs
Comments
 Rapid administration can cause bradycardia
RESPONSIBILITY
Policy Sponsor
Initial Endorsement
Last Reviewed
Last Amended
Review date
Chief Pharmacist
April 2015
April 2018
Do not keep printed versions of guidelines as currency of information cannot be guaranteed.
Access the current version from the WNHS website
2015
All guidelines should be read in conjunction with the Disclaimer at the beginning of this manual
Page 1 of 1